Augie’s Quest and ALS TDI
The purpose of Augie’s Quest has always been to fund research and drug development aimed at ending ALS, Lou Gehrig’s disease. Since 2007, Augie’s Quest has raised over $44 million in support of finding effective ALS treatments- making it the largest individual fundraising program for ALS!
All funds raised by Augie’s Quest benefit ALS TDI, the world’s largest ALS-dedicated drug development organization. Support comes from a huge network of national events and promotions, including the BASH for Augie’s Quest, Tradition of Hope Gala and widely successful campaigns within the very generous fitness industry, such as the Clubs for the Quest, as well as a hugely innovative joint-fundraising initiative called the ClubCorp Charity Classic which benefits Augie’s Quest and other local charities chosen by that networks members directly.
The ALS Therapy Development Institute (ALS TDI) is the world’s leader in ALS research. Our mission has precise focus: to discover and develop effective treatments to end ALS. As a nonprofit biotech, ALS TDI combines the ambition and strategy of a pharmaceutical company with the dedicated spirit of a 501c3, with incredible flexibility to expedite promising potential treatments from lab bench to people living with the disease today. Founded by a patient and his family, and featuring PALS and their loved ones in the highest leadership roles, a sense of urgency and perseverance drives every decision made at the Cambridge, MA-based institute.